Publications by authors named "Marius Brunner"

Claim this Profile
A
ADJUBIL: phase II study of adjuvant immunotherapy with STRIDE regimen with/without capecitabine in biliary tract cancers.
Thorsten Goetze, Maria A Gonzalez-Carmona, Lisa Kochen, Nihat Bugra Agaoglu, Salah-Eddin Al-Batran, Marius Brunner

Future Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Metastasis or sarcoidosis - a diagnostic pitfall in metastatic rectal carcinoma].
Marius Brunner, Christoph Ammer-Herrmenau, Lorenz Biggemann, Philipp Ströbel, Alexander König

Z Gastroenterol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axon guidance receptor ROBO3 modulates subtype identity and prognosis via AXL-associated inflammatory network in pancreatic cancer.
Niklas Krebs, Lukas Klein, Florian Wegwitz, Elisa Espinet, Hans Carlo Maurer, Marius Brunner

JCI Insight· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of fourth-line dual immunotherapy in hepatocellular carcinoma with simultaneous steroid administration for immune-related hepatitis.
Kristina Lowes, Johanna Reinecke, Marius Brunner, Matthias Scholz, Julia Kitz

Therap Adv Gastroenterol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cure Is Possible: Extensively Metastatic HER2-Positive Gastric Carcinoma with 5 years of Complete Remission after Therapy with the FLOT Regimen and Trastuzumab.
Sebastian Schade, Ute Koenig, Ardian Mekolli, Jochen Gaedcke, Albrecht Neesse, Marius Brunner

Case Rep Gastroenterol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain metastases in gastroesophageal cancers-an underestimated complication.
Marius Brunner, Dominik Soll, Kathrin Adler, André Sasse, Ute König

Gastric Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EZH2 Regulates Pancreatic Cancer Subtype Identity and Tumor Progression via Transcriptional Repression of .
Shilpa Patil, Benjamin Steuber, Waltraut Kopp, Vijayalakshmi Kari, Laura Urbach, Marius Brunner

Cancer Res· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer.
Andrii Khomiak, Marius Brunner, Maximilian Kordes, Stina Lindblad, Rainer Christoph Miksch

Cancers (Basel)· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytosolic 5'-nucleotidase 1A is overexpressed in pancreatic cancer and mediates gemcitabine resistance by reducing intracellular gemcitabine metabolites.
Melanie S Patzak, Vijayalakshmi Kari, Shilpa Patil, Feda H Hamdan, Robert G Goetze, Marius Brunner

EBioMedicine· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammation-induced NFATc1-STAT3 transcription complex promotes pancreatic cancer initiation by KrasG12D.
Sandra Baumgart, Nai-Ming Chen, Jens T Siveke, Alexander König, Jin-San Zhang, Marius Brunner

Cancer Discov· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis